Anticholinergic medication and dental caries status in middle-aged xerostomia patients-a retrospective study

[1]  D. Kopycka-Kedzierawski,et al.  Anticholinergic medication-related dry mouth and effects on the salivary glands. , 2021, Oral surgery, oral medicine, oral pathology and oral radiology.

[2]  C. Csajka,et al.  Quality of anticholinergic burden scales and their impact on clinical outcomes: a systematic review , 2020, European Journal of Clinical Pharmacology.

[3]  J. Jones,et al.  Caries prevalence and associations with medications and medical comorbidities , 2018, Journal of public health dentistry.

[4]  K. Johnell,et al.  The Effect of Xerostomic Medication on Oral Health in Persons With Dementia. , 2018, Journal of the American Medical Directors Association.

[5]  M. Zins,et al.  Anticholinergic drug use and cognitive performances in middle age: findings from the CONSTANCES cohort , 2018, Journal of Neurology, Neurosurgery, and Psychiatry.

[6]  S. Hartikainen,et al.  Anticholinergic burden and dry mouth among Finnish, community‐dwelling older adults , 2018, Gerodontology.

[7]  D. Jager,et al.  Clinical oral dryness score: evaluation of a new screening method for oral dryness , 2018, Odontology.

[8]  K. Johnell,et al.  Medications That Cause Dry Mouth As an Adverse Effect in Older People: A Systematic Review and Metaanalysis , 2018, Journal of the American Geriatrics Society.

[9]  M. Fromm,et al.  Anticholinergic burden and cognitive function in a large German cohort of hospitalized geriatric patients , 2017, PloS one.

[10]  L. Tune.  Perspective: Serum Anticholinergic Drug Level Determinations after 30 Years. , 2016, The American journal of geriatric psychiatry.

[11]  Mengmeng Du,et al.  Trends in Dietary Supplement Use Among US Adults From 1999-2012. , 2016, JAMA.

[12]  M. Turner.  Hyposalivation and Xerostomia: Etiology, Complications, and Medical Management. , 2016, Dental clinics of North America.

[13]  Mary Jordan Samuel.  American Geriatrics Society 2015 Updated Beers Criteria for Potentially Inappropriate Medication Use in Older Adults , 2015, Journal of the American Geriatrics Society.

[14]  Michael L. Johnson,et al.  Potentially Inappropriate Anticholinergic Medication Use in Community-Dwelling Older Adults: A National Cross-Sectional Study , 2015, Drugs & Aging.

[15]  S. Duffull,et al.  Anticholinergic burden quantified by anticholinergic risk scales and adverse outcomes in older people: a systematic review , 2015, BMC Geriatrics.

[16]  P. Enright,et al.  Pro-arrhythmic and pro-ischaemic effects of inhaled anticholinergic medications , 2012, Thorax.

[17]  R. V. Vander Stichele,et al.  Systematic review of anticholinergic risk scales in older adults , 2013, European Journal of Clinical Pharmacology.

[18]  K. Engedal,et al.  Higher anticholinergic drug scale (ADS) scores are associated with peripheral but not cognitive markers of cholinergic blockade. Cross sectional data from 21 Norwegian nursing homes. , 2013, British journal of clinical pharmacology.

[19]  Vicki L Burt,et al.  Prescription drug use continues to increase: U.S. prescription drug data for 2007-2008. , 2010, NCHS data brief.

[20]  E. Simonsick,et al.  Drug burden index score and functional decline in older people. , 2009, The American journal of medicine.

[21]  B. Pollock,et al.  Anticholinergic Activity of 107 Medications Commonly Used by Older Adults , 2008, Journal of the American Geriatrics Society.

[22]  M. Navazesh,et al.  Measuring salivary flow: challenges and opportunities. , 2008, Journal of the American Dental Association.

[23]  R. McGlinchey,et al.  The anticholinergic risk scale and anticholinergic adverse effects in older persons. , 2008, Archives of internal medicine.

[24]  B. Pollock,et al.  The Anticholinergic Drug Scale as a Measure of Drug‐Related Anticholinergic Burden: Associations With Serum Anticholinergic Activity , 2006, Journal of clinical pharmacology.

[25]  R. Poulton,et al.  The impact of xerostomia on oral-health-related quality of life among younger adults , 2006, Health and quality of life outcomes.

[26]  Mitchell J Barnett,et al.  Anticholinergic medications in community-dwelling older veterans: prevalence of anticholinergic symptoms, symptom burden, and adverse drug events. , 2006, The American journal of geriatric pharmacotherapy.

[27]  Professionally applied topical fluoride: evidence-based clinical recommendations. , 2006, Journal of the American Dental Association.

[28]  C. Scully,et al.  Drug effects on salivary glands: dry mouth. , 2003, Oral diseases.

[29]  W. Thomson,et al.  Is medication a risk factor for dental caries among older people? , 2002, Community dentistry and oral epidemiology.

[30]  S. Higham,et al.  Age and medication are significant risk factors for xerostomia in an English population, attending general dental practice. , 2001, Gerodontology.

[31]  A. Bardow,et al.  Relationships between medication intake, complaints of dry mouth, salivary flow rate and composition, and the rate of tooth demineralization in situ. , 2001, Archives of oral biology.

[32]  L. Sreebny,et al.  A reference guide to drugs and dry mouth--2nd edition. , 1997, Gerodontology.

[33]  R. Billings.  An epidemiologic perspective of saliva flow rates as indicators of susceptibility to oral disease. , 1993, Critical Reviews in Oral Biology and Medicine.

[34]  L. Tune,et al.  ASSOCIATION OF POSTOPERATIVE DELIRIUM WITH RAISED SERUM LEVELS OF ANTICHOLINERGIC DRUGS , 1981, The Lancet.